je.st
news
Mannkind to triple Afrezza production
2015-04-27 23:45:31| Biotech - Topix.net
Executives with Mannkind are tripling their production capacity at their local manufacturing facility in the hopes that demand for their drug Afrezza will continue to increase in the coming months. Afrezza, the first inhalable and fast acting insulin, hit the market in February after several years in development by the drug company.
Tags: production
triple
afrezza
mannkind
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||